Christopher Scott Hill's Net Worth
$2.52 Million
Who is Christopher Scott Hill?
Christopher Scott Hill has an estimated net worth of $2.52 Million. This is based on reported shares across multiple companies, which include CORE LABORATORIES N V, and Core Laboratories Inc. /DE/.
SEC CIK
Christopher Scott Hill's CIK is 0001641315
Past Insider Trading and Trends
2017 was Christopher Scott Hill's most active year for acquiring shares with 7 total transactions. Christopher Scott Hill's most active month to acquire stocks was the month of November. 2016 was Christopher Scott Hill's most active year for disposing of shares, totalling 10 transactions. Christopher Scott Hill's most active month to dispose stocks was the month of November. 2024 saw Christopher Scott Hill paying a total of $0.00 for 79,442 shares, this is the most they've acquired in one year. In 2022 Christopher Scott Hill cashed out on 44,158 shares for a total of $252,766.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CORE LABORATORIES N V No price found
SVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +20.53% | 19.22K |
$20.27 | -$252,766.90 | 112.81K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +25.08% | 14.27K |
$22.31 | -$206,568.29 | 71.17K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| +10.43% | 1.58K |
$26.51 | -$27,146.24 | 16.68K |
Dec 31
| |||
Form 4
| +0.19% | 29 |
$9.49 | -$227.76 | 15.11K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +10.68% | 1.46K |
$37.67 | -$35,598.15 | 15.08K |
Dec 31
| |||
Form 4
| +0.21% | 28 |
$68.93 | -$1,723.25 | 13.62K |
Apr 1
| |||
Form 4
| +0.40% | 54 |
$67.37 | -$3,099.02 | 13.6K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +15.52% | 1.82K |
$59.66 | -$70,458.46 | 13.54K |
Dec 31
| |||
Form 4
| +0.65% | 76 |
$114.55 | -$5,612.95 | 11.72K |
Sep 1
| |||
Form 4
| +0.32% | 37 |
$108.22 | -$1,731.52 | 11.65K |
Apr 1
| |||
Form 4
| +0.61% | 70 |
$102.99 | -$3,089.70 | 11.61K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +23.28% | 2.18K |
$109.55 | -$89,940.55 | 11.54K |
Dec 29
| |||
Form 4
| +0.97% | 90 |
$105.04 | -$3,676.40 | 9.36K |
Dec 1
| |||
Form 4
| +0.98% | 90 |
$89.59 | -$3,135.65 | 9.27K |
Sep 1
| |||
Form 4
| +0.38% | 35 |
$115.52 | -$2,079.36 | 9.18K |
Apr 1
| |||
Form 4
| +0.74% | 67 |
$118.74 | -$3,918.42 | 9.15K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +1.00% | 90 |
$116.14 | -$4,064.90 | 9.08K |
Dec 1
| |||
Form 4
| +1.22% | 108 |
$112.33 | -$4,717.86 | 8.99K |
Oct 1
| |||
Form 4
| +1.02% | 90 |
$111.43 | -$3,900.05 | 8.88K |
Sep 1
| |||
Form 4
| +0.40% | 35 |
$108.31 | -$1,949.58 | 8.79K |
Apr 1
| |||
Form 4
| +0.77% | 67 |
$108.38 | -$3,576.54 | 8.76K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +1.05% | 90 |
$117.72 | -$4,120.20 | 8.69K |
Dec 1
| |||
Form 4
| +1.27% | 108 |
$99.02 | -$4,158.84 | 8.6K |
Oct 1
| |||
Form 4
| +1.07% | 90 |
$111.66 | -$3,908.10 | 8.49K |
Sep 1
| |||
Form 4
| +2.66% | 218 |
$114.04 | -$9,351.28 | 8.4K |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Core Laboratories Inc. /DE/ (CLB) Snapshot price: $17.69
SVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4/A
| -16.46% | -14.20K |
$17.66 | -$250,683.70 | 72.05K |
Dec 31
| |||
Form 4
| +16.28% | 22.2K |
$17.66 | -$244,944.20 | 158.62K |
Dec 31
| |||
No matching records found |